Han, Y <br/><br/>
Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation sequencing.  [electronic resource] 

 -  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases  Aug 2015 
 - 797.e1-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1469-0691 
<br/><br/><label>Standard No.: </label>10.1016/j.cmi.2015.03.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Female<br/>Genetic Variation<br/>Hepatitis B virus--enzymology<br/>Hepatitis B, Chronic--drug therapy<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Lamivudine--therapeutic use<br/>Male<br/>Prognosis<br/>RNA-Directed DNA Polymerase--genetics<br/>ROC Curve<br/>Retrospective Studies<br/>Sequence Analysis, DNA<br/>Treatment Outcome<br/>Viral Load